Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
The Mainland University Study Subsidy Scheme 2022/23 is open for applications from Hong Kong students until September 30, the Education Bureau announced today.
Covering 191 designated Mainland institutions, including 129 institutions participating in the 2022/23 Scheme for Admission of Hong Kong Students to Mainland Higher Education Institutions, the scheme benefits most local students with different financial needs who pursue undergraduate studies in the Mainland.
While the scheme is not subject to a quota, applicants may only receive either a means-tested subsidy or a non-means-tested subsidy in the same academic year.
The subsidy is granted on a yearly basis and the subsidised period covers the normal duration of the undergraduate programme pursued by the student concerned in the designated Mainland institution.
Eligible students may enrol online or by post. The application result is expected to be released by the first quarter of 2023.
http://dlvr.it/SVrSc5
http://dlvr.it/SVrSc5